At first, the monovalent influenza A (H5N8) vaccine will be tested in two doses, 21 days apart, in adults aged 18–59.

The vaccine to be administered in Finland is designed off a different avian influenza virus called H5N8, but researchers say the shot should still confer protection against H5N1.

A supercharged HIV vaccine could offer strong protection with just one injection, a study in mice has indicated.. Developed by researchers from the Massachusetts Institute of Technology (MIT) and ...

Experts warn about risks of new COVID-19 vaccine guidelines 04:32. The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for ...

At the same time, federal officials have prepared about 10 million doses of H5N8 vaccine that they think will be effective against H5N1 bird flu, in case the virus becomes more dangerous.

In 2010, the H5N8 strain of HPAIV belonging to clade 2.3.4.4 was detected for the first time in wild Asian birds. The infection later spread among domestic birds in South Korea, Japan, and China.

At the same time, federal officials have prepared about 10 million doses of H5N8 vaccine that they think will be effective ...

COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...

The authors note that the U.S. government is readying 4.8 million doses of stockpiled H5N8 vaccine, which is expected to offer cross-protection against current H5N1 strains.

The study in healthy adults 18 years of age and older is split into two stages, with part A evaluating four vaccine candidates against H5N8, H7N9, H5 only, and H7 only, and part B zeroing in on a ...

The MMR vaccine protects against measles, mumps and rubella, or German measles. It is a live virus vaccine, which means it contains a weakened version of the germs that cause the diseases.